South Korea Grants USD 9M to Boost Emergency Healthcare in Upper Egypt
The initiative will introduce mobile clinics, upgrade emergency rooms, and provide specialised training for emergency personnel.
Feb 14, 2025
Minister of Health Khaled Abdel Ghaffar met with South Korean Ambassador Kim Yonghyon to announce a USD 9 million project, which will enhance emergency medical services in Upper Egypt, focusing on the Nag Hammady and Luxor region.
The initiative, which coincides with South Korea's ongoing railway modernisation projects in the area, will introduce mobile clinics, upgrade emergency rooms, supply advanced equipment, and provide specialised training for emergency personnel starting in 2026.
The meeting also highlighted Egypt's participation in the Dr. LEE Jong-wook Fellowship Program, offering training in infectious disease response and health policy leadership. Additionally, a USD 10 million investment by Korea's Choong Ang Vaccine Laboratories Co., Ltd. (CAVAC) and Egypt's Giza Power Industry (GPI) will establish a poultry vaccine production facility in Al-Sadat City, set to open in June.
Further collaboration includes a Korean Biomedical Business Delegation visit to Egypt in September and a reception celebrating 30 years of diplomatic ties on April 13th.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
4 hours ago
- Daily News Egypt
Egypt's pharmaceutical market hits EGP 309bn in 2024, marking 43% growth
Egypt's pharmaceutical market recorded EGP 309bn in sales in 2024, up from EGP 216bn in 2023—reflecting a 43% year-on-year increase, according to Ali Ghamrawy, Chairperson of the Egyptian Drug Authority (EDA). The announcement came during the EDA's 15th Board of Directors meeting, attended by Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport Kamel El-Wazir, Minister of Investment and Foreign Trade Hassan Mohamed El-Khatib, and Presidential Health Advisor Mohamed Awad Tag El-Din, alongside other senior officials. The meeting reviewed several strategic updates, including the latest activities of the Permanent Committee of the Egyptian Pharmacopeia and progress in digital transformation across the Authority. These digital initiatives aim to enhance service delivery efficiency and strengthen the institutional work environment. A key highlight of the meeting was the EDA's continued success in gaining international accreditation. In December 2024, the World Health Organization (WHO) awarded the Authority Maturity Level 3 status in the field of medicines—an achievement that follows its earlier Maturity Level 3 accreditation for vaccines in March 2022. EDA laboratories have also been accredited by both the WHO and the European Union, a milestone that positions them as globally recognized reference labs. The Authority's growing international presence was further underscored by its contributions to regulatory capacity-building programs across the Arab and African regions. With WHO Maturity Level 3 recognition in both medicine and vaccine regulation, the EDA has assumed a leading role in supporting regulatory system development throughout Africa. The African Union Development Agency – NEPAD (AUDA-NEPAD) has selected EDA's Continuing Professional Development Center as a Regional Centre of Regulatory Excellence (RCORE). Under this designation, the Authority has conducted 12 international training programs for countries including Libya, Yemen, Ghana, and Algeria. Additionally, the meeting showcased progress in EDA's internship programs, including the pilot launch of a new Learning Management System (LMS) platform aimed at enhancing professional training and knowledge transfer.
Daily News Egypt
a day ago
- Daily News Egypt
Egypt becomes first country in Eastern Mediterranean to meet WHO target for hepatitis B control
Egypt has become the first country in the World Health Organization's Eastern Mediterranean Region to meet the WHO target for hepatitis B control, a milestone achievement officially recognized during a ceremony held in Cairo on Sunday. At the event, Deputy Prime Minister and Minister of Health Khaled Abdel Ghaffar received a formal certificate from WHO, confirming Egypt's success in achieving the benchmark for reducing hepatitis B prevalence among children and maintaining sustained vaccine coverage. According to national surveys conducted between 2008 and 2024, hepatitis B prevalence among individuals under 60 has declined by 15% since 2015, while rates among children under ten have dropped by 50%. Notably, prevalence among children under five now stands at below 1%—the threshold established by WHO for hepatitis B control. WHO Regional Director for the Eastern Mediterranean, Hanan Balkhy, praised Egypt's public health infrastructure and long-standing commitment to immunization. She highlighted that Egypt has maintained over 90% coverage of the hepatitis B third-dose vaccine for more than a decade, as well as consistent coverage of the birth dose for five consecutive years. 'This is a turning point in Egypt's healthcare journey,' said Abdel Ghaffar. 'It reflects our national commitment to prevention, immunization, and universal health coverage, in alignment with President Abdel Fattah Al-Sisi's vision for health security.' The success was largely driven by Egypt's Expanded Program on Immunization (EPI), which achieved over 95% vaccine coverage, providing free hepatitis B vaccines to all newborns—Egyptian and non-Egyptian alike. The program also ensures immediate birth doses and immunoglobulin for infants born to hepatitis B-positive mothers. Egypt also expanded immunization access to high-risk populations, including healthcare workers, dialysis patients, people living with HIV, and household contacts of hepatitis B carriers. These efforts were supported by upgrades to the digital infrastructure that improved vaccine tracking, reduced waste, and ensured equitable service delivery across the country. WHO Representative in Egypt, Naeema Al-Gasseer, commended Egypt for its technical capacity and long-term planning. 'Egypt fully deserves this recognition. It is a testament to what can be achieved through coordinated health policy and sustained investment in public health.' Beyond immunization, the Ministry of Health launched the Egyptian Vaccine Manufacturers Alliance (EVMA) to localize vaccine production and strengthen domestic supply chain resilience, a key pillar in Egypt's drive toward health system sustainability. Hesham Sateet, Head of the Unified Procurement Authority, emphasized the importance of securing vaccines and medical supplies through transparent, efficient mechanisms. 'This achievement would not have been possible without the full backing of Egypt's political leadership and the close coordination among state institutions,' he said. Ali El-Ghamrawy, President of the Egyptian Drug Authority, added that local manufacturing and regulatory governance are central to Egypt's broader health strategy, which is aligned with Vision 2030 and the UN Sustainable Development Goals. 'The Egyptian experience proves that with strategic planning, institutional coordination, and political will, even complex public health challenges can be overcome,' Abdel Ghaffar concluded, expressing gratitude to frontline health workers and international partners who supported Egypt's journey.
CairoScene
3 days ago
- CairoScene
General Authority for Healthcare Digitises Foreign Patient Services
To streamline treatment access, GAH has partnered with 25 global insurers to deliver unified care packages. Jun 01, 2025 The General Authority for Healthcare (GAH) has announced that it has provided care for over 24,000 foreign patients from 97 countries, generating more than USD 4.5 million in revenue as part of its ongoing push to position Egypt as a regional hub for medical tourism. Operating under its flagship initiative, 'We Care for You in Egypt', GAH has expanded specialised services in fields such as cardiology, orthopaedics, cosmetic procedures, and general surgery. The authority's facilities have seen growing demand following a comprehensive digital transformation programme that includes digitised patient records, automated booking systems, and integrated follow-up care protocols—all aimed at aligning services with international standards. As part of efforts to streamline medical access and financial processing, GAH has signed agreements with 25 international health insurance companies. These partnerships allow the authority to offer unified medical packages that address both the clinical and financial needs of incoming patients, including pre-travel consultations and post-operative care. These developments form part of a national strategy to increase Egypt's competitiveness in the global medical tourism sector. Key components of this strategy include strengthening digital infrastructure, expanding internationally accredited hospitals, and building a care pathway that spans the full patient journey—from initial outreach to post-discharge recovery.
